STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.

$22.13  -1.07 (-4.61%)
As of 12/03/2021 11:25:46 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Pharmaceutical Retailers
Index country:  Italy
Country of incorporation:  
IPO date:  07/16/2021
Outstanding shares:  0
Average volume:  354,988
Market cap:   $13,614,412,720
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   7.76
PS ratio:   14.70
Return on equity:   15.59%
Net income %:   15.09%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy